Clinical Trials Logo

Hypoxia clinical trials

View clinical trials related to Hypoxia.

Filter by:

NCT ID: NCT03637140 Completed - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on pulmonary artery pressure and right heart function (echo) under exercise.

NCT ID: NCT03637127 Completed - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Cognitive Function

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover Trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on cognitive functions.

NCT ID: NCT03637114 Completed - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS)

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover trial in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary Hypertension (CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on blood and tissue oxygenation (ABGA, near infrared spectroscopy)

NCT ID: NCT03637088 Completed - Clinical trials for Pulmonary Hypertension

Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo)

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Randomized crossover trial in patients with Pulmonary Hypertension (PAH, CTEPH) to assess the acute response to simulated altitude (FiO2:15.1, equivalent to 2500m above sea level) on pulmonary artery pressure and right heart function (Echo).

NCT ID: NCT03635450 Completed - Clinical trials for Moderate to Severe Hypoxic-ischemic Encephalopathy

Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE

Start date: December 27, 2018
Phase: Phase 1
Study type: Interventional

To determine the safety of single and repeated intravenous doses of hCT-MSC in newborn infants with HIE.

NCT ID: NCT03630016 Completed - Hypoxia Clinical Trials

SpO2 Accuracy Comparison of Smart Sock V. 2 SpO2 to Arterial Blood CO-Oximetry

Start date: December 13, 2017
Phase: N/A
Study type: Interventional

Pulse oximetry monitoring is considered a standard physiological measurement and is used by clinicians in everyday situations to estimate arterial oxygen saturation. There are two devices used in this investigational study: BabySat v.1.0 and Owlet Baby Care, Inc. Smart SockTM 2 (currently available over-the-counter), with specific emphasis on its pulse oximetry accuracy. The BabySat and Smart SockTM 2 are non-invasive home care devices for use with infants. The purpose of this study was to validate the SpO2 accuracy of BabySat v1.0 and Owlet Smart SockTM 2, OSS v1.1 sensors pulse oximetry, during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry.

NCT ID: NCT03625700 Completed - Oxygen Deficiency Clinical Trials

Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day Mortality

SOSAM
Start date: January 1, 2014
Phase:
Study type: Observational

This study evaluates the use and effects of supplementary oxygen in surgical and medical wards on patients admitted to a hospital in the capital region of Denmark. The population will be divided in to three groups according to their oxygenation status. The main outcome will be 30-day mortality, with secondary outcomes being Length of stay, 30-day admission to ICU, 30-day reoperations, 30-day readmission, and peak values within 30-days of C-reactive protein, S-Creatinine, Troponin.

NCT ID: NCT03621891 Completed - Clinical trials for Chronic Periodontitis

Alterations in Subgingival Microbiota and Hypoxia in Occlusal Trauma

Start date: May 1, 2016
Phase:
Study type: Observational

Present study suggests that excessive occlusal forces did not cause a significant change in hypoxia and vascular markers, however a slight alteration in subgingival microbiota was observed.

NCT ID: NCT03606434 Completed - Clinical trials for Healthy Participants

Sex Differences in Reflex Responses to Intermittent Hypoxia

Start date: September 13, 2018
Phase: N/A
Study type: Interventional

The purpose of the present study is to determine whether there are sex differences in the reflex responses to hypoxia in humans.

NCT ID: NCT03600181 Completed - Clinical trials for Intubation Complication

Non-invasive Technology for Early Signal Detection of Hypoxemia With ORI During Intubation

NESOI
Start date: February 11, 2019
Phase:
Study type: Observational

Intubation of patients in the intensive care unit (ICU) carries a risk of potentially severe complications, including cardiac arrest. Hypoxemia is common in ICU patients requiring intubation, which must be performed rapidly to avoid aspiration, since the patient is usually not in the fasted state. Studies have assessed interventions designed to improve intubation success rates, such as routine neuromuscular blockade. Care bundles combined with training on simulators have improved the safety of intubation. Nevertheless, intubation in the ICU still carries higher morbidity and mortality rates compared to intubation in the operating room. Preoxygenation is a cornerstone of safety for intubation in the ICU. Several recent trials have investigated different devices (non-rebreather mask, non-invasive ventilation, high flow nasal cannula, bag valve mask) with conflicting results. A main reason for those results is that efficiency of the preoxygenation period cannot be evaluated in the ICU in opposite to the operating room: gas monitoring are not available in ICU and even if it was the case, high flow demand from the patient, and agitation will make it inefficient. Additionally, desaturation is frequent (from 10% up to 50%) during intubation in ICU and lead to morbidity and mortality; so anticipation of desaturation is a major concern for ICU's physician because it's impacting care (face mask ventilation, early insertion of subglottic device). The oxygen reserve index (ORI) is a new parameter for monitoring oxygen reserve non-invasively. In this context, the investigators purpose to analyze efficiency of preoxygenation and time allowed by ORI for medical interventions before hypoxemia during intubation in the ICU in a pilot observational study in our medical ICU in a university hospital.